DocMorris Competitors

DOCM Stock

6.01 0.12 1.96%

DocMorris AG competes with IVF Hartmann, Coltene Holding, Newron Pharmaceuticals, Santhera Pharmaceuticals, and Molecular Partners; as well as few others. Analyzing DocMorris competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of DocMorris to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of DocMorris competition on your existing holdings.

Specify up to 10 symbols:

DocMorris Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between DocMorris and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of DocMorris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of DocMorris AG does not affect the price movement of the other competitor.

	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE
VBSN		0.44	0.57	0.37	0.0	0.3	0.3	-0.24	-0.3	VBSN
CLTN	0.44		0.92	0.89	0.55	-0.08	0.87	-0.81	-0.67	CLTN
NWRN	0.57	0.92		0.86	0.59	0.07	0.78	-0.71	-0.6	NWRN
SANN	0.37	0.89	0.86		0.59	-0.21	0.85	-0.78	-0.6	SANN
MOLN	0.0	0.55	0.59	0.59		-0.23	0.58	-0.65	-0.28	MOLN
ASCN	0.3	-0.08	0.07	-0.21	-0.23		-0.22	0.39	0.25	ASCN
SHLTN	0.3	0.87	0.78	0.85	0.58	-0.22		-0.77	-0.63	SHLTN
ADXN	-0.24	-0.81	-0.71	-0.78	-0.65	0.39	-0.77		0.72	ADXN
EVE	-0.3	-0.67	-0.6	-0.6	-0.28	0.25	-0.63	0.72		EVE
	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE

High positive correlations

NWRN	+ 0.92	CLTN
SANN	+ 0.89	CLTN
SHLTN	+ 0.87	CLTN
SANN	+ 0.86	NWRN
SHLTN	+ 0.85	SANN
SHLTN	+ 0.78	NWRN

High negative correlations

ADXN	- 0.81	CLTN
ADXN	- 0.78	SANN
ADXN	- 0.77	SHLTN
ADXN	- 0.71	NWRN
EVE	- 0.67	CLTN
ADXN	- 0.65	MOLN

Risk-Adjusted Indicators

There is a big difference between DocMorris Stock performing well and DocMorris Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DocMorris' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VBSN	0.73	0.06	(0.01)	0.54	0.71	(1.13)	2.13	(1.45)	5.12
CLTN	1.58	0.35	0.13	(3.78)	1.71	(1.74)	3.19	(2.90)	10.00
NWRN	3.17	1.38	0.41	8.00	2.56	(4.03)	8.80	(4.69)	19.68
SANN	2.30	0.56	0.23	1.84	1.87	(2.93)	6.06	(3.65)	17.54
MOLN	2.79	0.32	0.05	(0.32)	3.29	(3.33)	7.50	(5.28)	22.81
ASCN	1.62	0.00	(0.03)	0.10	1.76	(1.87)	3.22	(2.76)	8.56
SHLTN	7.82	1.88	0.22	9.37	7.08	(11.09)	20.00	(12.31)	92.47
ADXN	2.61	(0.07)	0.00	0.17	0.00	0.00	6.56	(6.15)	15.01
EVE	3.11	(0.04)	0.00	0.23	0.00	0.00	8.00	(6.82)	23.73

Unable to evaluate fundamental data of DocMorris AG at this time. Please try again later

All Fundamental Data

DocMorris Competitive Analysis

The better you understand DocMorris competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, DocMorris' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across DocMorris' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	DOCM	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE
	1.96 6.01 DocMorris	0.70 144.00 IVF	0.18 55.70 Coltene	6.85 30.40 Newron	0.95 14.56 Santhera	2.42 3.38 Molecular	1.09 3.71 Ascom	1.75 1.12 SHLTN	2.89 0.06 Addex	6.02 0.78 Evolva
Market Volatility (90 Days Market Risk)	Slightly risky	Very steady	Very steady	Not too volatile	Not too volatile	Very risky	Slightly risky	Out of control	Out of control	Abnormally volatile
Market Performance (90 Days Performance)	Weak	Mild	Good	Strong	Solid	Mild	Weak	Fair	Weakest	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Unknown	Low	Low	Small	Small	Low	Low	Small	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Over Valued	Under Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Cautious Hold	Strong Sell	Cautious Hold	Strong Buy	Strong Sell	Sell	Strong Sell	Strong Sell	Strong Sell
Current Ratio		4.56	1.35	13.9	2.19	14.37	1.73	1.43	18.06	4.57
Net Asset		173.19 M	186.74 M	50.49 M	91.12 M	172.67 M	194.7 M	129.59 M	22.54 M	156.17 M
Profit Margin		0.0507	0.0947	-2.44	N/A	0.62	0.0295	-0.064	N/A	N/A
EBITDA		13.27 M	48.05 M	(11.76 M)	(34.57 M)	(60.67 M)	30.9 M	2.38 M	(14.94 M)	(31.82 M)
Operating Margin		0.0575	0.13	-1.84	-386.18	0.61	0.0305	-0.0114	-17.07	-2.31
Current Valuation		247.54 M	476.1 M	32.84 M	58.16 M	(39.23 M)	260.61 M	223.17 M	2.92 M	91.22 M
Price To Book		2.01	4.45	7.98	30.52	0.89	4.45	4.51	1.62	0.75
Five Year Return		1.36	2.9	N/A	N/A	N/A	2.97	N/A	N/A	N/A
Beta		0.46	0.98	1.11	0.8	0.62	1.54	0.64	1.88	0.71
Number Of Employees		312	1.19 K	25	39	163	1.33 K	3	26	62
Shares Outstanding		2.4 M	5.98 M	17.85 M	61.81 M	36.04 M	35.99 M	15.61 M	115.35 M	1.11 B
Cash Flow From Operations		(2.51 M)	32.52 M	(11.45 M)	(37.36 M)	(90.95 M)	11.6 M	185 K	(14.71 M)	(29.79 M)
Annual Yield		0.0169	0.045	N/A	N/A	N/A	0.0244	0.17	N/A	N/A
Total Debt		428 K	75 K	42.93 M	27 M	4.85 M	N/A	28.36 M	194.32 K	3.57 M
Return On Equity		0.0544	0.26	-8.4	-13.16	0.62	0.12	-0.063	-2.03	-0.37
Z Score		N/A	N/A	0.6	0.6	26.4	1.0	4.2	87.0	15.0
Return On Asset		0.0315	0.11	-0.16	-0.49	0.32	0.0303	-0.004	-0.88	-0.11
Book Value Per Share		57.29	17.24	-0.29	-0.25	7.73	1.82	3.58	0.15	0.1
Total Asset		173.19 M	186.74 M	50.49 M	91.12 M	172.67 M	194.7 M	129.59 M	22.54 M	156.17 M
Last Dividend Paid		1.9	3.3	N/A	N/A	N/A	0.2	N/A	N/A	N/A
Debt To Equity		N/A	84.2	0.7	196.0	0.02	24.0	2.4	N/A	1.6
Target Price		N/A	83.5	4.35	4.0	13.98	12.09	10.5	0.16	0.28
Shares Owned By Institutions		1.23	24.38	7.28	3.5	45.01	47.93	21.78	9.31	25.03
Market Capitalization		273.6 M	442.78 M	81.91 M	50.45 M	215.91 M	295.15 M	219.7 M	28.26 M	90.05 M
Price To Earning		25.67	25.3	-11.88	-7.01	2.02	21.86	6.77	39.53	-4.33
Price To Sales		1.85	1.68	3.95	276.19	1.19	0.93	3.66	9.82	7.35
Net Income		6.21 M	31.71 M	(14.9 M)	(55.53 M)	(63.78 M)	13.5 M	(14.11 M)	(15.35 M)	(41.27 M)
Earnings Per Share		3.09	4.3	-0.85	-1.62	3.53	0.24	-0.97	-0.53	-0.047
Shares Owned By Insiders		71.77	56.3	4.96	18.77	14.13	4.47	46.8	8.96	0.66
Revenue		144.07 M	279.24 M	5.76 M	(1.59 M)	9.33 M	291.5 M	49.58 M	2.92 M	9.88 M
Cash And Equivalents		29.35 M	25.73 M	58.99 M	21.21 M	267.13 M	29.5 M	576 K	20.48 M	11 M
Cash Per Share		14.98	3.43	3.31	2.07	8.22	0.59	0.84	1.58	0.08
Gross Profit		74.11 M	187.45 M	5.76 M	(5.36 M)	(45.96 M)	136.7 M	24.59 M	(9.69 M)	(8.81 M)
Day Typical Price	6.04	143.33	55.73	30.15	14.47	3.35	3.69	1.12	0.0553	0.78
Accumulation Distribution	5406.11	0.0139	21.94	0.0906	11471.47	159.88	2739.11	2.92	35602.28	494.66
Market Facilitation Index	0.0	2.0	2.0E-4	2.85	0.0	0.0	0.0	0.0024	N/A	0.0
Daily Balance Of Power	(0.46)	0.5	(0.20)	0.6842	(0.12)	1.0	0.3333	(0.22)	0.32	(1.67)
Period Momentum Indicator	(0.12)	1.0	(0.10)	1.95	(0.14)	0.08	0.04	(0.02)	0.0016	(0.05)
Rate Of Daily Change	0.98	1.01	1.0	1.07	0.99	1.02	1.01	0.98	1.03	0.94
Day Median Price	6.05	143.0	55.75	30.03	14.42	3.34	3.68	1.13	0.0545	0.79
Price Action Indicator	(0.10)	1.5	(0.10)	1.35	0.07	0.08	0.05	(0.01)	0.0033	(0.03)
Coefficient Of Variation	3182.91	1271.56	572.79	292.79	556.69	1513.74	6239.41	650.77	(2,799)	(7,829)
Mean Deviation	2.37	0.7295	1.58	3.17	2.3	2.79	1.62	7.82	2.61	3.11
Jensen Alpha	0.1143	0.0597	0.3472	1.38	0.5588	0.3175	0.0041	1.88	(0.07)	(0.04)
Total Risk Alpha	(0.27)	(0.05)	0.1127	0.9296	0.2099	(0.20)	(0.20)	0.4906	(0.54)	(0.58)
Sortino Ratio	0.0019	(0.01)	0.1272	0.4085	0.2278	0.0465	(0.03)	0.2167	N/A	N/A
Downside Variance	9.3	1.16	4.03	10.31	4.84	12.94	3.4	69.86	N/A	N/A
Standard Deviation	3.19	1.03	2.0	4.12	3.32	3.96	2.0	12.4	3.56	4.51
Kurtosis	1.44	1.06	0.2615	0.6582	4.21	2.87	(0.43)	11.82	0.1174	1.39
Potential Upside	5.02	2.13	3.19	8.8	6.06	7.5	3.22	20.0	6.56	8.0
Treynor Ratio	(0.32)	0.5433	(3.78)	8.0	1.84	(0.32)	0.1034	9.37	0.1734	0.23
Maximum Drawdown	16.58	5.12	10.0	19.68	17.54	22.81	8.56	92.47	15.01	23.73
Variance	10.17	1.05	4.01	16.95	10.99	15.65	4.01	153.78	12.7	20.36
Market Risk Adjusted Performance	(0.31)	0.5533	(3.77)	8.01	1.85	(0.31)	0.1134	9.38	0.1834	0.24
Risk Adjusted Performance	0.031	0.0612	0.1361	0.2622	0.1414	0.0573	0.0182	0.1237	(0.02)	(0)
Skewness	0.1946	0.6801	(0.23)	0.2277	1.55	0.6764	0.3404	2.47	0.1685	0.8289
Semi Deviation	2.94	0.7058	1.71	2.56	1.87	3.29	1.76	7.08	N/A	N/A
Information Ratio	0.0019	(0.01)	0.1275	0.3186	0.1512	0.0422	(0.03)	0.1461	(0.06)	(0.03)
Value At Risk	(4.43)	(1.45)	(2.90)	(4.69)	(3.65)	(5.28)	(2.76)	(12.31)	(6.15)	(6.82)
Expected Short fall	(2.63)	(1.13)	(1.74)	(4.03)	(2.93)	(3.33)	(1.87)	(11.09)	N/A	N/A
Downside Deviation	3.05	1.08	2.01	3.21	2.2	3.6	1.84	8.36	N/A	N/A
Semi Variance	8.65	0.4981	2.92	6.56	3.48	10.83	3.08	50.1	N/A	N/A

DocMorris Competition Performance Charts

Five steps to successful analysis of DocMorris Competition

DocMorris' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by DocMorris AG in relation to its competition. DocMorris' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of DocMorris in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact DocMorris' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to DocMorris AG, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your DocMorris position

In addition to having DocMorris in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Repeal Thematic Idea Now

Obamacare Repeal

Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 40 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC